Furthermore, TGF-β inhibits the export of iron by reducing the expression of FPN and affects iron storage by decreasing ferritin light chain 1 (FLH1) expression, which impacts ovarian cancer development, progression, drug resistance, and prognosis [220]. This evidence concerns the gene SLC40A1 and ovarian carcinoma.